COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATEDONCOSEC MEDICAL Inc • May 18th, 2023 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______[1] (the “Termination Date”) but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 18th, 2023 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 16, 2023, between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 27th, 2011 • ONCOSEC MEDICAL Inc • Services-business services, nec
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 24, 2011, between Oncosec Medical Incorporated, a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SERIES A COMMON STOCK PURCHASE WARRANT oncosec medical incorporatedONCOSEC MEDICAL Inc • November 13th, 2017 • Pharmaceutical preparations
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [______]1 provided, however, that this Warrant shall not be exercisable, in whole or in part, at any time prior to the exercise in full and for cash that certain warrant (the “Original Warrant”) to purchase Common Stock issued to the original Holder hereof pursuant to the Securities Purchase Agreement (the “Purchase Agreement”) dated as of October [25] [22]2, 2017 between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), Holder, and the other signatories thereto (the date upon this Warrant becomes exercisable, “Initial Exercise Date”) and on or prior to the close of business on [______]3 (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, up to [______] shares
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2015 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 3, 2015 between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 26th, 2017 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 25, 2017, between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, a “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 6th, 2011 • ONCOSEC MEDICAL Inc • Services-business services, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 21, 2011, between Oncosec Medical Incorporated, a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
OncoSec Medical Incorporated Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • November 2nd, 2018 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
OncoSec Medical Incorporated, a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATEDONCOSEC MEDICAL Inc • November 5th, 2015 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May , 2016 (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
7,711,284 Shares ONCOSEC MEDICAL INCORPORATED Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 21st, 2021 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATEDONCOSEC MEDICAL Inc • November 19th, 2012 • Services-business services, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Oncosec Medical Incorporated, a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATEDCommon Stock Purchase • March 29th, 2012 • ONCOSEC MEDICAL Inc • Services-business services, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Oncosec Medical Incorporated, a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
13,333,334 Shares[1] OncoSec Medical Incorporated Common Stock PURCHASE AGREEMENTPurchase Agreement • February 2nd, 2018 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
OncoSec Medical Incorporated, a Nevada corporation (the “Company”) proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 13,333,334 shares (the “Firm Shares”) of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 2,000,000 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
COMMON STOCK PURCHASE WARRANT ONCOSEC MEDICAL INCORPORATEDONCOSEC MEDICAL Inc • May 23rd, 2019 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. New York time on May 24, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from OncoSec Medical Incorporated, a Nevada corporation (the “Company”), up to ______ shares of common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
OncoSec Medical IncorporatedONCOSEC MEDICAL Inc • February 1st, 2023 • Pharmaceutical preparations • New York
CONFIDENTIAL OncoSec Medical IncorporatedONCOSEC MEDICAL Inc • May 24th, 2016 • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 29th, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • Nevada
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of March 29, 2019 by and between ONCOSEC MEDICAL INCORPORATED, a Nevada corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
UNDERWRITING AGREEMENT between OncoSec Medical Incorporated and as Representative of the Several Underwriters ONCOSEC MEDICAL INCORPORATEDUnderwriting Agreement • May 23rd, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
The undersigned, OncoSec Medical Incorporated, a Nevada corporation (collectively with its subsidiary, OncoSec Medical Australia Pty, Ltd., hereinafter referred to as the “Subsidiary,” the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
LEASE AGREEMENTLease Agreement • January 2nd, 2015 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations
THIS LEASE AGREEMENT (this “Lease”) is made this 31 day of December, 2014, between ARE-SD REGION NO. 18, LLC, Delaware limited liability company (“Landlord”), and ONCOSEC MEDICAL INCORPORATED, a Nevada corporation (“Tenant”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 1st, 2022 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of November 30, 2022, between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 17th, 2020 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of August 16, 2020, is by and among OncoSec Medical Incorporated, a Nevada corporation with headquarters located at 24 North Main Street, Pennington, NJ 08534-2218 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 28th, 2023 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of [ ], 2023, between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
LEASE AGREEMENTLease Agreement • December 13th, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations
THIS LEASE AGREEMENT (this “Lease”) is made this 20 day of November, 2019, between 3535/3565 GENERAL ATOMICS COURT, LLC, a Delaware limited liability company (“Landlord”), and ONCOSEC MEDICAL INCORPORATED, a Nevada corporation (“Tenant”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • November 13th, 2017 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This Warrant Exercise Agreement (this “Agreement”), dated as of November __, 2017, is by and between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and the undersigned holders (collectively, the “Holder”) of warrants to purchase shares of the Company’s common stock, no par value (the “Common Stock”).
ONCOSEC Medical incorporated EQUITY DISTRIBUTION AGREEMENT Dated: July 25, 2017Equity Distribution Agreement • July 25th, 2017 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
LOCK-UP AGREEMENTLock-Up Agreement • November 23rd, 2022 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
Re: Securities Purchase Agreement, dated as of November ___, 2022 (the “Purchase Agreement”), between OncoSec Medical Incorporated (the “Company”) and the purchasers signatory thereto
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 10th, 2020 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (as it may be amended or modified from time to time, this “Agreement”) is made and entered into as of February 7, 2020 by and between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and Sirtex Medical US Holdings, Inc., a Delaware corporation (“Buyer”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 14th, 2011 • ONCOSEC MEDICAL Inc • Services-business services, nec • California
This Employment Agreement (the “Agreement”) is made this May 18, 2011, by and between OncoSec Medical Incorporated, a Nevada corporation (the “Company”) and Punit S. Dhillon (the “Employee” or “Executive”). The Company or Employee are sometimes referred to herein as “party” or collectively the “parties”.
COMMON STOCK PURCHASE WARRANT To Purchase 1,000,000 Shares of Common Stock of ONCOSEC MEDICAL INCORPORATEDCommon Stock Purchase Warrant • October 3rd, 2011 • ONCOSEC MEDICAL Inc • Services-business services, nec • California
THIS IS TO CERTIFY THAT Inovio Pharmaceuticals Inc., or registered assigns (the “Holder”), is entitled, during the Exercise Period (as hereinafter defined), to purchase from OncoSec Medical Incorporated, a Nevada corporation (the “Company”), the Warrant Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, at a purchase price of $1.20 per share, subject to adjustment as provided herein (the “Exercise Price”), all on and subject to the terms and conditions hereinafter set forth.
June 1, 2011Letter Agreement • October 11th, 2011 • ONCOSEC MEDICAL Inc • Services-business services, nec • New York
RESEARCH AND DEVELOPMENT SERVICES AGREEMENTResearch and Development Services Agreement • July 1st, 2016 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • California
THIS RESEARCH AND DEVELOPMENT SERVICES AGREEMENT (“Agreement”) is being entered into as of this 6th day of March, 2015 (the “Effective Date”), by and between OncoSec Medical Incorporated, a Nevada Corporation with a principal place of business at 9810 Summers Ridge Rd., Ste. 110, San Diego, CA 92121 (the “Company”), and Rev.1 Engineering Inc., a California Corporation, having a principal place of business at 41693 Date Street, Murrieta, CA 92562 (“Rev.1”). Rev.1 and Company are at times referred to individually as a “Party” and jointly as the “Parties.”
Services AgreementServices Agreement • October 11th, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This Services Agreement (“Agreement”), dated as of October 10, 2019, is by and between OncoSec Medical Incorporated, a Nevada corporation (“OncoSec”), and Sirtex Medical US Holdings, Inc., a Delaware corporation (“Sirtex”) (each, a “Party” and, collectively, the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • September 6th, 2016 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), dated September 1, 2016 (the “Effective Date”), is between OncoSec Medical Incorporated (the “Company”) and Sharron Gargosky (“Executive”).
STOCK PURCHASE AGREEMENT by and between Sirtex Medical US Holdings, Inc. “Purchaser” and OncoSec Medical Incorporated “Issuer” Dated as of October 10, 2019Stock Purchase Agreement • October 11th, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 10, 2019 by and between Sirtex Medical US Holdings, Inc., a Delaware corporation (“Purchaser”), and OncoSec Medical Incorporated, a Nevada corporation (“Issuer”). Certain capitalized terms used in this Agreement are defined in Section 11.1.
STOCKHOLDERS AGREEMENTStockholders Agreement • October 11th, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
THIS STOCKHOLDERS AGREEMENT (as may be amended or modified from time to time, this “Agreement”) is made and entered into as of October 10, 2019, by and between OncoSec Medical Incorporated, a Nevada corporation (the “Company”), and Sirtex Medical US Holdings, Inc. (“Buyer”).
